Dispatches from China
Deciphering the Chinese consumer
As P&G and L’Oreal discovered, the consumers are constantly evolving and arriving at the right mix of low-end and high-end offerings is not easy
Category : strategy-and-innovation
The importance of being Team Indus
If Team Indus succeeds in soft landing a spacecraft on the moon and wins the Lunar X Prize, it could set the stage for the company and India to be a big player in space engineering
Virtuoso
How collective ingenuity is changing the world
Innovation strategist Navi Radjou discusses how innovation in the engineering space is moving away from big proprietary labs, why India and the emerging markets are the next big thing, and what leaders can do to manage these different themes
The jump to BS-VI and what it means for innovation
The switch to the new emission norms will lead to interesting shifts in the automotive and energy industries
Holacracy, managerless offices and the future of work
Brian Robertson, co-founder of HolacracyOne, gives an overview of his revolutionary new self-management system
The state of cancer research and the future of innovation
In India, a focus on public health initiatives and re-engineering of proven drugs and treatments to reduce costs will achieve better results than looking for new cures
Dispatches from China
Family comes first at Starbucks China
What can companies whose job roles don’t fit the traditional notions of a good career choice, do to retain staff? Starbucks CEO Howard Schultz has a creative solution
New Rules of Business
Why is Amazon pumping money into India and other stories
Business strategist Rajesh Srivastava analyses some of the news that dominated headlines in February 2016: Alphabet vs. Apple, Amazon’s push in India and the entry of godmen in business
Tracking the progress of innovation in India
There is an urgent need to measure and track whether we are harnessing our creative potential to solve the important problems in education, health and agriculture
Intellectual property rights: When it’s broken, fix it!
We need affordable medicines and we need more innovation. It’s time to reinvent the patents regime
Editors Picks
Latest